<DOC>
	<DOCNO>NCT02858804</DOCNO>
	<brief_summary>The purpose study : 1. determine efficiency EDOCH ( etoposide , dexamethasone , doxorubicin , cyclophosphamide vincristine ) alternate DHAP ( cisplatin , cytarabine dexamethasone ) regimen combine rituximab young mantle cell lymphoma patient ( age≤65 year ) ; 2. determine efficiency rituximab thalidomide plus prednisone maintenance regimen .</brief_summary>
	<brief_title>EDOCH Alternating With DHAP New Diagnosed Younger MCL</brief_title>
	<detailed_description>Enrolled patient receive EDOCH ( etoposide , dexamethasone , doxorubicin , cyclophosphamide vincristine ) ±R /DHAP ( cisplatin , cytarabine dexamethasone ) ±R alternate chemotherapy . If partial remission well response achieves , patient recommend receive autologous stem cell transplantation consideration therapy another two cycle EDOCH ±R /DHAP±R chemotherapy ( base patient 's choice ) . Patients less partial remission ( PR ) response quit study . After treatment finish , maintenance therapy rituximab thalidomide plus prednisone give less two year . The determination maintenance regimen dependent patient choice .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Mantle-Cell</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Cytarabine</mesh_term>
	<mesh_term>Thalidomide</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>age≤65 year diagnosis mantle cell lymphoma Ann Arbor stage II , III IV ECOG≤1 ECOG≥2 recover pretreatment . centre neural system involvement serious complication uncontrolled diabetes , gastric ulcer serious angiocardiopathy determine physician HIV positive active HBV infection uncontrolled systematic infection clinical central nervous dysfunction serious surgery within 30 day pregnancy baby nursing period uncontracepted child bearing period woman .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>mantle cell lymphoma</keyword>
	<keyword>EDOCH</keyword>
	<keyword>DHAP</keyword>
	<keyword>maintenance therapy</keyword>
</DOC>